Trial0

Clinical trial · NCT03747588 · RECRUITING · NA

The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer

Sponsor: Peking Union Medical College Hospital

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

Minimally invasive pancreaticoduodenectomy remains one of the most challenging abdominal procedures. Safety and feasibility remain controversial when comparing minimally-invasive with open pancreaticoduodenectomy, especially for malignant tumors.The aim of this study was to compare minimally invasive and open pancreatoduodenectomy for short-term outcomes and long-term follow-up in a randomized trial.

Interventions

  • Minimally-invasive pancreaticoduodenectomy · PROCEDURE

    Minimally-invasive pancreaticoduodenectomy for resection of pancreatic tumor

  • Open pancreaticoduodenectomy · OTHER

    Open pancreaticoduodenectomy for resection of pancreatic tumor

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Age: \>18yr, \<75yr
* Patients with pancreatic cancer or non-pancreatic cancers (biliary duct cancer or ampullary cancer) who underwent pancreatoduodenectomy
* Preoperative imaging assessment is resectable or borderline resectable

Exclusion Criteria:

* Benign tumors of the head of pancreas
* Enhanced CT diagnosis revealed that the excess of SMV was more than 180 degrees, or distant metastasis.
* conversion to laparotomy because of intraoperative difficulty

Sites (1)

  • Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing, Beijing Municipality, China · RECRUITING

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2022-10-03.